Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial.

Br J Cancer · 2009 · PMC2768086 · PMID 19789532

Europe PMC DOI

hedged sentence

0.0770

closest p · 1.5× alpha

0.0770

boldest claim

The sentences

did not reach statistical significanceP =0.077so close (0.05 < p ≤ 0.1)

Curative-intent hepatic resection rate was higher in 350 patients treated with oxaliplatin-based combination chemotherapy (71 out of 350 patients; 20.3%) than in those treated with irinotecan combination chemotherapy (33 out of 230patients; 14.5%) although the difference did not reach statistical significance ( P =0.077).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.